8-KOther EventsExhibits & Filings

JOHNSON & JOHNSON 8-K Report, Corporate Update (Oct 1, 2007)

Filed October 1, 2007For Securities:JNJ

Summary

This 8-K filing from Johnson & Johnson reports on a significant development concerning its subsidiary, DePuy Orthopaedics, Inc. On September 27, 2007, DePuy reached an agreement with the U.S. Attorney's Office for the District of New Jersey to resolve a government investigation into past sales practices within the orthopaedics industry. This resolution is a crucial event for investors as it brings closure to a previously disclosed legal and regulatory matter, potentially mitigating ongoing uncertainty and future liabilities associated with the investigation. The primary impact for investors lies in the finalization of this particular investigation. While the details of the agreement are not fully disclosed within this 8-K itself, the filing indicates that a statement from DePuy Orthopaedics, dated September 27, 2007, is attached as an exhibit. Investors should review this attached statement for further specifics regarding the terms of the resolution, any potential financial implications, and the scope of the agreement. This development is important for assessing the company's legal and compliance posture.

Key Highlights

  • 1DePuy Orthopaedics, a Johnson & Johnson subsidiary, reached an agreement with the U.S. Attorney's Office for the District of New Jersey.
  • 2The agreement resolves a previously reported government investigation into sales practices in the orthopaedics industry.
  • 3The event date is September 26, 2007, with the filing date of October 1, 2007.
  • 4A statement from DePuy Orthopaedics, dated September 27, 2007, is attached as an exhibit to the 8-K filing.
  • 5This filing addresses Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

Frequently Asked Questions

The main purpose of this 8-K filing is to disclose that Johnson & Johnson's subsidiary, DePuy Orthopaedics, Inc., has reached an agreement with the U.S. Attorney's Office for the District of New Jersey to resolve a government investigation into its past sales practices.

The government investigation focused on sales practices within the orthopaedics industry, specifically concerning DePuy Orthopaedics, Inc.

More details about the agreement are expected to be found in the statement issued by DePuy Orthopaedics, Inc. on September 27, 2007, which is attached as Exhibit 99.1 to this 8-K filing.

This specific 8-K filing does not explicitly detail any financial penalties or fines. Investors should refer to the attached DePuy Orthopaedics statement (Exhibit 99.1) for potential information on the terms of the resolution, which may include financial aspects.